检索结果-南通市图书馆

Emerging role of caldesmon in cancer:A potential biomarker for colorectal cancer and other cancers

World journal of Gastrointestinal Oncology 2022年第9期14卷 1637-1653页

作者： Alya R Alnuaimi Vidhya A Nair lara j bou m.lhab Eman Abu-Gharbieh Anu Vinod Ranade Gianfranco Pintus mohamad Hamad Hauke Busch jutta Kirfel Rifat Hamoudi Wael m Abdel-Rahman Sharjah Institute for medical Research University of SharjahSharjah 27272United Arab Emirates College of medicine University of SharjahSharjah 27272United Arab Emirates Department of Clinical Sciences University of SharjahSharjah 27272United Arab Emirates Department of Basic medical Sciences University of SharjahSharjah 27272United Arab Emirates Department of medical Laboratory Sciences University of SharjahSharjah 27272United Arab Emirates Department of Biomedical Sciences University of SassariSassari 07100Italy University Cancer Center Schleswig-Holstein and Luebeck Institute for Experimental Dermatology University of LuebeckLuebeck 23560Germany Institute of Pathology University Hospital Schleswig-HolsteinLuebeck 23560Germany Division of Surgery and Interventional Science University College LondonLondon WC1E 6BTUnited Kingdom

Colorectal cancer(CRC) is a devastating disease, mainly because of metastasis. As a result, there is a need to better understand the molecular basis of invasion and metastasis and to identify new biomarkers and therapeutic targets to aid in managing these tumors. The actin cytoskeleton and actin-binding proteins are known to play an important role in the process of cancer metastasis because they control and execute essential steps in cell motility and contractility as well as cell division. Caldesmon(CaD) is an actin-binding protein encoded by the CALD1 gene as multiple transcripts that mainly encode two protein isoforms: High-molecular-weight CaD, expressed in smooth muscle, and low-molecular weight CaD(l-CaD), expressed in nonsmooth muscle cells. According to our comprehensive review of the literature, CaD, particularly l-CaD, plays a key role in the development, metastasis, and resistance to chemoradiotherapy in colorectal, breast, and urinary bladder cancers and gliomas, among other malignancies. CaD is involved in many aspects of the carcinogenic hallmarks, including epithelial mesenchymal transition via transforming growth factor-beta signaling, angiogenesis, resistance to hormonal therapy, and immune evasion. Recent data show that CaD is expressed in tumor cells as well as in stromal cells, such as cancerassociated fibroblasts, where it modulates the tumor microenvironment to favor the tumor. Interestingly, CaD undergoes selective tumor-specific splicing, and the resulting isoforms are generally not expressed in normal tissues, making these transcripts ideal targets for drug design. In this review, we will analyze these features of CaD with a focus on CRC and show how the currently available data qualify CaD as a potential candidate for targeted therapy in addition to its role in the diagnosis and prognosis of cancer.

关键词： Bladder cancer CALD1 Caldesmon Chemoresistance Colorectal cancer Gastric cancer Glioma Epithelial to mesenchymal transition Invasion metastasis

来源：

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

欢迎您,

建议与咨询留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

时间限定

文献类型

馆藏选择

核心期刊

语言

文献类型

帮助

文字说明：

检索规则说明：

检索范例：

分类表

所选分类

限定检索结果

文献类型

馆藏范围

日期分布

学科分类号

主题

机构

作者

语言

在线全文

请选择保存的检索档案：

请选择收藏分类：

通借通还

欢迎您,

建议与咨询 留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

时间限定

文献类型

馆藏选择

核心期刊

语言

文献类型

帮助

文字说明：

检索规则说明：

检索范例：

分类表

所选分类

限定检索结果

文献类型

馆藏范围

日期分布

学科分类号

主题

机构

作者

语言

在线全文

请选择保存的检索档案： 新增检索档案 确定 取消

请选择收藏分类： 新增自定义分类 确定 取消

通借通还

建议与咨询留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

请选择保存的检索档案：

请选择收藏分类：